Product
Laninamivir
1 clinical trial
2 indications
Indication
InfluenzaIndication
HumanClinical trial
ADaptive ASsessment of TReatments for influenzA: A Phase 2 Multi-centre Adaptive Randomised Platform Trial to Assess Antiviral Pharmacodynamics in Early Symptomatic Influenza Infection (AD ASTRA)Status: Recruiting, Estimated PCD: 2027-01-01